Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma

Trial Profile

Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma

Recruiting
Phase of Trial: Phase II

Latest Information Update: 24 Jan 2017

At a glance

  • Drugs Dasatinib (Primary) ; Irinotecan; Sirolimus; Temozolomide
  • Indications Neuroectodermal tumours
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Apr 2016 Status changed from not yet recruiting to recruiting.
    • 07 Nov 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top